Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

XLABExascale Labs Holdings Inc.

Nasdaq · CIK 0002109869
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC7372 Services-Prepackaged Software
FY end0630
XBRL facts111

Identity from submissions API

NameExascale Labs Holdings Inc.
CIK0002109869
TickersXLAB, XLABW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC7372 Services-Prepackaged Software
EIN000000000
LEI—
Fiscal year end0630
State of incorporationDE DE
Phone(650) 537-7553
Website—
Investor website—
Owner org06 Technology
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • D. Boral ARC Merger Corp (2026-06-26T04:00:00.000Z → 2026-07-07T04:00:00.000Z)
Business address
820 GESSNER ROAD, SUITE 332
HOUSTON
TX
77024
TX
Mailing address
820 GESSNER ROAD, SUITE 332
HOUSTON
TX
77024
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

35 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 424B3 424B3 0001829126-26-012527 333-299733 261562512 33 714347
2026-11-16 10-Q 10-Q 0001829126-26-012515 001-43465 261561773 34 6133045 1 1
2026-11-09 424B3 424B3 0001829126-26-012124 333-299733 261534350 33 84840
2026-11-09 8-K 8-K 1.01,9.01 0001829126-26-012120 001-43465 261534275 34 612617 1 1
2026-11-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003459 333-299733 261529161 33 1832
2026-11-05 424B3 424B3 0001829126-26-012039 333-299733 261528539 33 2148482
2026-10-30 S-1 S-1 0001829126-26-011834 333-299733 261508322 33 13495931 1 1
2026-10-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002162155-26-000003 005-95968 261502191 34 14679
2026-10-15 3 3 0001493152-26-047312 6563
2026-10-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-047255 005-95968 261463380 34 20210
2026-10-15 8-K 8-K 1.01,9.01 0001829126-26-011139 001-43465 261461090 34 349538 1 1
2026-10-06 4 FORM 4 0001829126-26-010804 6310
2026-10-06 4 FORM 4 0001829126-26-010803 6301
2026-10-06 4 FORM 4 0001829126-26-010802 6417
2026-10-06 4 FORM 4 0001829126-26-010801 6180
2026-10-05 3 FORM 3 0001829126-26-010773 3317
2026-09-30 8-K 8-K 5.02 0001829126-26-010623 001-43465 261427803 34 246026 1 1
2026-09-28 8-K 8-K 2.02,9.01 0001829126-26-010494 001-43465 261418214 34 314503 1 1
2026-09-28 8-K/A 8-K/A 2.01,9.01 0001829126-26-010463 001-43465 261414957 34 1272048 1 1
2026-09-28 10-K 10-K 0001829126-26-010462 001-43465 261414954 34 7009898 1 1
2026-09-08 3 FORM 3 0001829126-26-009866 5830
2026-09-08 3 FORM 3 0001829126-26-009865 3115
2026-09-08 3 FORM 3 0001829126-26-009864 3231
2026-09-08 3 FORM 3 0001829126-26-009862 11010
2026-09-08 3 FORM 3 0001829126-26-009861 3124
2026-09-08 8-K 8-K 5.02 0001829126-26-009860 001-43465 261364250 34 245393 1 1
2026-09-02 8-K 8-K 1.01,1.02,2.01,3.01,3.03,4.01,5.01,5.02,5.03,5.06,7.01,9.01 0001829126-26-009632 001-43465 261353150 34 1435777 1 1
2026-08-27 CERT 8A_CERT_XLAB_0002109869.pdf 0001354457-26-000826 001-43465 261329922 34 180286
2026-08-27 8-A12B 8-A12B 0001829126-26-009406 001-43465 261328633 34 25421
2026-07-07 424B3 424B3 0001829126-26-007331 333-297214 261158344 33 6998412
2026-07-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002186 333-297214 261147587 33 3446
2026-07-01 S-4 S-4 0001829126-26-007145 333-297214 261146638 33 19036831 1 1
2026-07-01 RW RW 0001829126-26-007134 333-297193 261144946 NE 11925
2026-07-01 S-4 S-4 0001829126-26-007124 333-297193 261144071 33 19036712 1 1
2026-06-26 S-4/A S-4/A 0001829126-26-006917 333-295869-02 261125855 33 20600552 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (111 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 87.60M 2026-09-02 2026 FY 10-K 2026-09-28 0001829126-26-010462
ffd NetFeeAmt NetFeeAmt USD 3,483.81 2026-10-29 2026 FY S-1 2026-10-30 0001829126-26-011834
ffd TtlFeeAmt TtlFeeAmt USD 3,483.81 2026-10-29 2026 FY S-1 2026-10-30 0001829126-26-011834
ffd TtlOfferingAmt TtlOfferingAmt USD 40.04M 2026-10-29 2026 FY S-1 2026-10-30 0001829126-26-011834
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-29 2026 FY S-1 2026-10-30 0001829126-26-011834
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-29 2026 FY S-1 2026-10-30 0001829126-26-011834
us-gaap AccountsAndFinancingReceivableAllowanceForCreditLoss Accounts and Financing Receivable, Allowance for Credit Loss USD 52,832 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 1.52M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.02M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AccountsReceivableNet Accounts Receivable, after Allowance for Credit Loss USD 1.52M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.58M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 590 2026-03-31 S-4 2026-07-01 0001829126-26-007145
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 50.43M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 153,266 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 52,832 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap Assets Assets USD 17.22M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AssetsCurrent Assets, Current USD 17.21M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap AssetsNoncurrent Assets, Noncurrent USD 11,275 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 12.83M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 12.83M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 10.14M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.5 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 14.10M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.01 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1,500 2026-01-08 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 1,500 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 1,500 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap CommonStockValue Common Stock, Value, Issued USD 15 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap CostOfRevenue Cost of Revenue USD 3.75M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 6,488 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap CryptoAssetSale CryptoAssetSale USD 6,488 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 3.01M 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 322,388 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.68M 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 7,985 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.01M 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap DepositContractsLiabilities Deposit Contracts, Liabilities USD 810,689 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap Depreciation Depreciation USD 1,565 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap Dividends Dividends USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.21 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.21 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.112 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure -0.027 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.004 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.09 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.088 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 153,266 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 1,500 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap ExcessStockSharesOutstanding Excess Stock, Shares Outstanding shares 1,500 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 612,768 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap GrossProfit Gross Profit USD 581,875 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -11.38M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncomeTaxesPaid Income Taxes Paid USD 800 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -243,703 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 1.11M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 431,848 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 590 2025-12-19 2025-12-31 S-4 2026-07-01 0001829126-26-007145
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -259,689 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD 49,034 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 701,630 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap Liabilities Liabilities USD 3.55M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 17.22M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.55M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 2,733 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 11.34M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -550,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -647,574 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -11.38M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -11.38M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NoncashOrPartNoncashAcquisitionInventoryAcquired1 Noncash or Part Noncash Acquisition, Inventory Acquired USD 3.00M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap NotesAssumed1 Notes Assumed USD 50,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap NotesIssued1 Notes Issued USD 1.50M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap OperatingExpenses Operating Expenses USD 2.12M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -1.54M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap OtherIncome Other Income USD 3,031 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap OtherReceivables Other Receivables USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 1.50M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 2.16M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2,138 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 15.09M 2022-10-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 11.80M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 785,257 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -11.38M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 29,198 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 11,275 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 17,923 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap PropertyPlantAndEquipmentOtherNet Property, Plant and Equipment, Other, Net USD 29,198 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 14,810 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 1.28M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -36.76M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap Revenues Revenues USD 4.33M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 227,334 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date pure 0.136 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.887 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 13.67M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 100 2026-03-31 S-4 2026-07-01 0001829126-26-007145
us-gaap StockIssued1 Stock Issued USD 100 2025-12-19 2025-12-31 S-4 2026-07-01 0001829126-26-007145
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 28.00M 2025-12-31 S-4 2026-07-01 0001829126-26-007145
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -1.36M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001829126-26-010462
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 55.30M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 55.30M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001829126-26-012515

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →